Status:
UNKNOWN
The Association of hsCRP and Radiotherapy-Induced Toxicity in Patients With Nasopharyngeal Carcinoma
Lead Sponsor:
Jiarong Chen, MD
Conditions:
Nasopharyngeal Carcinoma
Head and Neck Cancer
Eligibility:
All Genders
18-70 years
Brief Summary
The primary purpose of this study is to explore the association of high sensitivity C-reactive protein (hsCRP) and radiotherapy(RT)-induced toxicity in patients with nasopharyngeal carcinoma. In each ...
Eligibility Criteria
Inclusion
- Patients were pathologically newly diagnosed with nasopharyngeal carcinoma and had no previous history of other tumors
- According to the treatment strategies of doctors, patients need to receive radiotherapy with or without chemotherapy (for example, neoadjuvant chemotherapy, concurrent chemotherapy, adjuvant chemotherapy) or targeted therapy
- Willingness to sign the informed consent and return to enrolling institution for follow-up and data collection
Exclusion
- Patients do not conform to the inclusion criteria
- Pregnant or Nursing women
- Men or women of childbearing potential who are unwilling to employ adequate contraception
- Vital organs dysfunction(for example, kidneys, heart, liver, lungs, brain)
- Other contraindications or unsuitable conditions for radiotherapy
Key Trial Info
Start Date :
June 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2021
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04303975
Start Date
June 1 2021
End Date
December 1 2021
Last Update
June 11 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.